Influvac Tetra


Suspension for injection in pre-filled syringe 1
scheduling status
S2
registration number
52/30.1/0094
What Influvac Tetra is and what it is used for
Prophylaxis of influenza, especially those who run an increased risk of associated complications. Influvac Tetra is indicated in adults and children from 3 years of age. The use of Influvac Tetra should be based on official recommendations.
dosage
Adults: 0.5 ml. Paediatric population: Children from 3 to 17 years of age: 0.5 ml. Children less than 9 years of age, who have not previously been vaccinated with a seasonal influenza vaccine: a second dose of 0.5 ml should be given after an interval of at least 4 weeks. Children less than 3 years of age: the safety and efficacy of Influvac Tetra have not been established.
how to take
Immunisation should be carried out by intramuscular or deep subcutaneous injection. Prepare the medicinal product before administration as follows: 1. The vaccine should be allowed to reach room temperature before use. 2.Shake before use. 3. Inspect visually prior to administration. 4. Any unused product or waste material should be disposed of in accordance with local requirements.
What Influvac Tetra contains
Influenza virus surface antigens (inactivated) (haemagglutinin and neuraminidase) of the following strains# per 0.5 ml dose: 1. A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/2570/2019, IVR-215) 15 micrograms HA ** 2. A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, IVR-208) 15 micrograms HA ** 3. B/Washington/02/2019-like strain (B/Washington/02/2019, wild type) 15 micrograms HA ** 4. B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type) 15 micrograms HA ** Key: # propagated in fertilised hens’ eggs from healthy chicken flocks; ** haemagglutinin.
other ingredients
Potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate and water for injections. Influvac Tetra may contain traces of eggs (such as ovalbumin, chicken proteins), formaldehyde, cetyltrimethylammonium bromide, polysorbate 80 or gentamicin, which are used during the manufacturing process.
Therapeutic classification
J07BB02. Influenza inactivated, split virus or surface antigen.
© 2026 SAHPRA. ALL RIGHTS RESERVED